The Hidden Challenge in Orthopedic Procedures: Why 20% of Joint Injections Miss Their Target

The Hidden Challenge in Orthopedic Procedures: Why 20% of Joint Injections Miss Their Target

How A-Tap™ addresses a critical accuracy problem that affects treatment outcomes

The Problem Hidden in Plain Sight
Intra-articular injections are among the most common orthopedic procedures, used to deliver corticosteroids, hyaluronic acid, and other therapeutic agents directly into joint spaces. Yet despite their widespread use, accuracy still presents a significant challenge.

In fact, accuracy rates vary dramatically based on the injection site and approach used:

• Blind knee injections show accuracy rates ranging from 58% to 89% depending on the approach
• A systematic review found that on average only 77% of knee injections enter accurately into the intra-articular cavity when using clinical landmarks as guidance
• A review of randomized control studies found that 20% of injections miss the correct site, failing to deliver medication effectively

Why Accuracy Matters
When an intra-articular injection misses its target, the consequences extend beyond mere inconvenience to clinical impact:

• Reduced therapeutic efficacy — Medications injected outside the joint space cannot provide their intended anti-inflammatory or lubricating effects
• False treatment failures — Patients may be considered non-responders when the real issue was improper needle placement
• Delayed relief — Patients continue to experience pain and functional limitations
• Increased healthcare costs — Additional procedures and treatments may be required

Current Solutions Have Limitations
While image-guided injections using ultrasound or fluoroscopy can improve accuracy significantly — with ultrasound-guided injections showing accuracy rates of 96% compared to 83.7% for blind injections — these approaches have practical limitations:

• Equipment requirements — Specialized imaging equipment isn’t always available in all clinical settings
• Time constraints — Image guidance adds procedural time
• Cost considerations — Additional equipment and training requirements
• Radiation exposure — Fluoroscopy involves radiation exposure for patients and staff

The Aspiration Challenge
Traditional practice often calls for joint aspiration before injection to confirm needle placement and remove synovial fluid. However, this creates 3 key workflow challenges:

1. Two procedures — Separate actions for aspiration and injection require changing syringes while needle is in intra-articular space
2. Needle repositioning — Changing syringes can disturb optimal needle placement
3. Workflow complexity — Additional steps increase procedure time and complexity

Research on the “backflow technique” has shown that confirming intra-articular placement through observation of spontaneous backflow of injected lidocaine can achieve 97% accuracy, but this still requires multiple steps and syringe changes.

A-Tap™: Engineering Solution to Clinical Challenge
A-Tap™ addresses these accuracy and workflow challenges through innovative design that enables both aspiration and injection through a single device with one integrated aspiration-injection system procedure.

Enhanced Accuracy
The integrated aspiration-injection system significantly minimizes needle movement by eliminating the need to change syringes or reposition the needle between aspiration and injection. This design maintains optimal positioning throughout the procedure – once proper placement is confirmed through aspiration, the injection can proceed immediately without disturbing the needle’s location. The system provides real-time confirmation of needle placement, as aspiration offers immediate feedback on whether the needle has successfully accessed the intra-articular space.

Streamlined Workflow
This approach creates a more efficient procedure with one single device, which reduces both patient discomfort and tissue trauma. The integrated design features a toggle switch that allows seamless transition between aspiration and injection modes without interrupting the procedure flow. These design elements contribute to reduced procedure time by eliminating unnecessary steps and syringe changes that would otherwise slow down the injection process.

Supporting Best Practice
The system facilitates aspiration by making it easier for clinicians to follow the recommended practice of aspirating before injection. It confirms site placement through the aspiration process, helping verify proper intra-articular positioning before medication delivery. Additionally, aspiration prior to injection increases the efficacy of hyaluronic acid or other drugs by ensuring that the injected medication is not diluted by synovial fluid. Lastly, the closed system design reduces contamination risk by maintaining a sterile pathway throughout both the aspiration and injection phases of the procedure.

Clinical Validation
A-Tap™ has achieved regulatory clearance (CE approved and 510(k) cleared) and is designed to work with standard injection techniques while addressing the fundamental challenge of needle placement accuracy that affects up to 20% of procedures.

The device’s design specifically addresses the findings from multiple studies showing that injection accuracy is “highly dependent on the portal of entry” and that even experienced practitioners can struggle with consistent accuracy in blind injections.

Beyond the Statistics: Patient Impact
While accuracy statistics provide important clinical context, the real impact is measured in patient outcomes:

• Faster pain relief when medications reach their intended target
• Improved treatment success rates through proper drug delivery
• Enhanced patient confidence in the effectiveness of their treatment
• Reduced need for repeat procedures when initial injections are properly placed

Looking Forward
As orthopedic medicine continues to evolve toward precision and evidence-based care, addressing fundamental challenges like injection accuracy becomes increasingly important. Devices like A-Tap™ represent a practical approach to improving procedural success rates without requiring significant changes to clinical workflows or equipment investments.

For more information: www.elcam-medical.com/a-tap/